Dr.T.V.Rao MD
Dr.T.V.Rao MD 1
General Characteristics of Bacillus
~ 60 species; Gram-positive or Gram-variable bacilli
• Large (0.5 x 1.2 to 2.5 x 10 um)
• Most are saprophytic contaminants or normal flora
• Bacillus anthracis is most important member
Produce endospores
Aerobic or facultatively anaerobic
Dr.T.V.Rao MD 4
Bacillus anthrax
Several landmarks
Dr.T.V.Rao MD 5
20,000-100,000 cases estimated globally/year
http://www.vetmed.lsu.edu/whocc/mp_world.htm
Dr.T.V.Rao MD
Animal Transmission
• Most commonly infected by ingestion from
contaminated soil or contaminated feed or bone
meal
Dr.T.V.Rao MD 7
Anthrax
• An infectious,
Usually fatal disease
of warm-blooded
animals, especially of
cattle and sheep,
caused by the
bacterium Bacillus
anthracis.
Dr.T.V.Rao MD 8
B. anthracis
Gram-positive, spore-forming, non-motile bacillus
Dr.T.V.Rao MD 9
Anthrax Bacilli
Dr.T.V.Rao MD 10
Bacillus anthracis
General characteristics
• Bacillus anthracis
• Large, Gram positive, non-motile
rod
• Vegetative form
and spores
• Nearly worldwide distribution
• Over 1,200 strains
Dr.T.V.Rao MD 11
Bacillus anthracis
• Gram + rod
• Facultative anaerobe
Dr.T.V.Rao MD 13
Endospore
• Oxygen required for sporulation
• 1 spore per cell
• dehydrated cells
– Highly resistant to heat, cold,
chemical disinfectants, dry periods
• Protoplast carries the material for
future vegetative cell
• Cortex provides heat and radiation
resistance
• Spore wall provides protection from
chemicals & enzymes
Dr.T.V.Rao MD 14
Gram Stain Morphology
of B. anthracis
• Broad, gram-positive
rod: 1–1.5 x 3–5 µ
• Oval, central to
subterminal spores: 1 x
1.5 µ with no significant
swelling of cell
• Spores usually NOT
present in clinical
specimens unless
exposed to atmospheric
O2
Dr.T.V.Rao MD 15
Mechanism of Infection
• Anthrax spores enter body
• Germinate & multiple in
lymph nodes
• PA, EF, LF excreted from
bacteria
• PA binds to TEM8.
• EF and/or LF binds
• Complex internalized by
endocytosis
• Acidification of endosome
• LF or EF crosses into cytosol
via PA mediated ion-
conductive channels
Dr.T.V.Rao MD 16
Cultural
characteristics
• Aerobe, facultative anaerobe
• Grows between 12 -45 c
• 2-3 mm colonies
• Edge like matted hair
• Medusa head appearance
• Blood agar Hemolytic colonies
Dr.T.V.Rao MD 17
Appearance of Anthrax
• String of pearl
appearance with
Pencillin
• Differentiates Anthrax
and Cereus
Dr.T.V.Rao MD 18
SELECTIVE MEDIUM
PLET
• Contain
• 1 polymyxins
• 2 Lysozyme
• 3 Ethylene dioxide
• 4 Tetra acetic acid
Contains EDTA
Dr.T.V.Rao MD 19
Biochemical Reactions
• Gelatin –
Inverted fir
tree
appearance
Dr.T.V.Rao MD 20
Biochemical
Reactions
• Glucose, Maltose
and Sucrose
fermented with
acid but no gas
• Catalase positive
Dr.T.V.Rao MD 21
Sterilization of environments Floor
space/shed/vehicle
• Preliminary disinfection using 10% formaldehyde; (1-1.5 It/
sq.m.) or 4%
• Gluteraldehydes for at least 2 hours
• Cleaning - by washing or scrubbing with hot water
• Final disinfection by one of the following disinfectants
applied for at least 2 hours.
• 10% formaldehyde
4% Gluteraldehydes
• 3% hydrogen peroxide or
• 1% per acetic acid
Dr.T.V.Rao MD 22
Wool and Hair
• By duckering process
(five stages) i.e.
• lmmersion in 0.25-0.3%
soda liquor
• Immersion in soap
liquor;
• Two immersions in 2%
formaldehyde solution;
and
• Rinsing in water
Dr.T.V.Rao MD 23
Antibiotics
• Pencillin
• Erythrocin
• Tetracycline
• Chloramphenicol
• Occasional strains
resistant to penicillin
are encountered
Dr.T.V.Rao MD 24
Transmitted
• The disease can be
transmitted to humans
through contact with
contaminated animal
substances, such as hair,
feces, or hides, and is
characterized by ulcerative
skin lesions
Dr.T.V.Rao MD 25
Criteria in Transmission
• Skin: direct skin contact with spores; in nature, contact
with infected animals or animal products (usually related
to occupational exposure)
• Respiratory tract: inhalation of aerosolized spores
• GI: consumption of undercooked or raw meat products or
dairy products from infected animals
• NO person-to-person transmission of inhalation or GI
anthrax
Dr.T.V.Rao MD 26
Anthrax Cycle
Dr.T.V.Rao MD 27
Pathogenesis
• The infectious dose of B.
anthracis in humans by any
route is not precisely known.
– Rely on primate data
– Minimum infection dose of
~ 1,000-8,000 spores
– LD50 of 8,000-10,000
spores for inhalation
• Virulence depends on 2
factors
– Capsule
– 3 toxins http://www.kvarkadabra.net/index.html?/biologija/teksti/biolosko_orozje.htm
Dr.T.V.Rao MD 28
Anthrax:
Clinical Presentation
Cutaneous
Inhalational
Gastrointestinal
Dr.T.V.Rao MD 29
Epidemiology
of Anthrax in
Animal and
Human Hosts
Dr.T.V.Rao MD 30
Three forms of Anthrax
• Cutaneous anthrax
– Skin
– Most common
– Spores enter to skin through small lesions
• Inhalation anthrax
– Spores are inhaled
Dr.T.V.Rao MD 32
Anthrax:
Cutaneous
Begins as a papule, progresses through a
vesicular stage to a depressed black necrotic
ulcer (Escher)
Edema, redness, and/or necrosis without
ulceration may occur
Form most commonly encountered in naturally
occurring cases
Incubation period: 1–12 days
Case-fatality:
Without antibiotic treatment—20%
With antibiotic treatment—1%
Dr.T.V.Rao MD 33
Anthrax:
Inhalational
A brief prodromal resembling a “viral-like”
illness, characterized by myalgia, fatigue,
fever, with or without respiratory
symptoms, followed by hypoxia and
dyspnea, often with radiographic evidence
of mediastinal widening.
Meningitis in 50% of patients
Rhinorrhea (rare)
Dr.T.V.Rao MD 34
• Glycocalyx
Capsule
– Sticky, gelatinous polymer
external to cell wall
• pX02 plasmid
Dr.T.V.Rao MD 35
Virulence Factors
• 1 Capsular polypeptide
• Anthrax Toxin
• Both are coded by separate plasmid
• The capsular polypeptide aids virulence by
inhibiting phagocytosis, loss of plasmid loss of
virulence
• How the live attenuated anthrax spore vaccine (
Sterne strain )
Dr.T.V.Rao MD 36
Anthrax Toxin
The toxin is a three factions
The edema factor, (OF Factor I )
The protective antigen factor ( PA or
Factor II )
The lethal factor ( LF or Factor III )
Individually they are not toxic
Dr.T.V.Rao MD 37
How Toxicity Manifests
Dr.T.V.Rao MD 38
TOXIGENICITY
• OF island adenyl cyclase which is activated only inside
the target cells leading to the intracellular
accumulation of cyclic AMP
• Responsible for edema and other biological effects of
toxin.
• Entry of LF toxin into the target cell causes cell death.
• Loss of plasmid which encodes anthrax toxin renders
the strain avirulant.
• Sterne vaccine strain devoid of Plasmid coding for the
capsule polysaccharide.
Dr.T.V.Rao MD 39
Pathogenesis
• Anthrax spores enter body
• Germinate & multiple in lymph nodes
• PA, EF, LF excreted from bacteria
• PA binds to TEM8.
• PA nicked by protease furin
– 20-kDa segment off leaving 63-kDa peptide
– Heptamer forms
• EF and/or LF binds
• Complex internalized by endocytosis
• Acidification of endosome
• LF or EF crosses into cytosol via PA mediated ion-conductive
channels
• LF cleaves MAPKK 1 & 2
• EF stimulates cAMP
Dr.T.V.Rao MD 40
Clinical Presentation of Anthrax
Cutaneous Anthrax
95% human cases are cutaneous infections
1 to 5 days after contact
Small, pruritic, non-painful papule at inoculation site
Papule develops into hemorrhagic vesicle & ruptures
Slow-healing painless ulcer covered with black Escher
surrounded by edema
Infection may spread to lymphatic's w/ local adenopathy
Septicemia may develop
20% mortality in untreated cutaneous anthrax
Dr.T.V.Rao MD 41
Cutaneous Anthrax
Dr.T.V.Rao MD 42
Anthrax: Cutaneous
Mediastinal widening
JAMA 1999;281:1735–1745
Dr.T.V.Rao MD 47
Mediastinal Widening and Pleural
Effusion on Chest X-Ray in Inhalational
Anthrax
Dr.T.V.Rao MD 48
Gastrointestinal Anthrax
• GI anthrax may follow after the
consumption of contaminated,
poorly cooked meat.
http://science.howstuffworks.com/anthrax1.htm Dr.T.V.Rao MD 49
Clinical Presentation of Anthrax
Inhalation Anthrax
Virtually 100% fatal (pneumonic)
Meningitis may complicate cutaneous
and inhalation forms of disease
Pharyngeal anthrax
• Fever
• Pharyngitis
• Neck swelling
Dr.T.V.Rao MD 50
Clinical Presentation of Anthrax
Gastrointestinal (Ingestion) Anthrax
Dr.T.V.Rao MD 53
Diagnosis in Humans
• Anthrax quick ELISA test
– New test approved by FDA on June 7th, 2004.
– Detects antibodies produced during infection with
Bacillus anthracis
– Quicker and easier to interpret than previous antibody
testing methods
• Results in less than ONE hour
Dr.T.V.Rao MD 54
Clues to diagnosis
Dr.T.V.Rao MD 55
Laboratory Criteria for
Identification of B. anthracis
• From clinical samples, such as blood,
cerebrospinal fluid (CSF), skin lesion
(eschar), or oropharyngeal ulcer
– Encapsulated gram-positive rods on Gram
stain
• From growth on sheep blood agar:
– Large gram-positive rods
– Nonmotile
– Nonhemolytic
Dr.T.V.Rao MD 56
Anthrax:
Diagnosis
Inhalational
Chest X-ray—widened mediastinum,
pleural effusions, infiltrates, pulmonary
congestion
Affected tissue biopsy for
immunohistochemistry
Any available sterile site fluid for Gram
stain, PCR, or culture
Pleural fluid cell block for
immunohistochemistry
Dr.T.V.Rao MD 57
B. anthracis:
Confirmatory Identification
Isolate
Capsule DFA
Phage
lysis Capsule antigen
Horse Bicarbonate
Cell wall
blood media
(M’Fadyean (M’Fadyean stain
Stain) India ink stain)
Dr.T.V.Rao MD 58
B. anthracis:
Presumptive Identification
Dr.T.V.Rao MD 59
Laboratory Criteria for
Identification of B. anthracis
• From clinical samples, such as blood,
cerebrospinal fluid (CSF), skin lesion
(eschar), or oropharyngeal ulcer
– Encapsulated gram-positive rods on Gram
stain
• From growth on sheep blood agar:
– Large gram-positive rods
– Nonmotile
– Nonhemolytic
Dr.T.V.Rao MD 60
Laboratory Criteria for
Identification of B. anthracis
• Rapid screening assay (PCR- and antigen-
detection based) for use on cultures and
directly on clinical specimens
• Confirmatory criteria for identification of
B. anthracis
– Capsule production
– Lysis by gamma-phage
– Direct fluorescent antibody assay (DFA)
Dr.T.V.Rao MD 61
PCR Assay
• Detection time:
- PCR only takes several hours
ex) Rapid-cycle RT-PCR can be finished within 1-2 hours
• There are many different types of PCR assays for the detection of
Anthrax such as multiplex PCR, enter bacterial repetitive
intragenic consensus-PCR (ERIC-PCR), and long-range repetitive
element polymorphism-PCR.
Dr.T.V.Rao MD 63
Treatment & Prophylaxis
Treatment
• Penicillin is drug of choice
• Erythromycin, chloramphenicol acceptable alternatives
• Doxycycline now commonly recognized as prophylactic
Vaccine (controversial)
Laboratory workers
Employees of mills handling goat hair
Active duty military members
Potentially entire populace of U.S. for herd immunity
Dr.T.V.Rao MD 64
Treatment
• Penicillin
– Has been the drug of choice
– Some strains resistant to penicillin and doxycycline
• Ciprofloxacin
– Chosen as treatment of choice in 2001
– No strains known to be resistant
• Doxycycline may be preferable
Dr.T.V.Rao MD 65
Treatment
• Before 2001, 1st line of treatment was
penicillin G
– Stopped for fear of genetically
engineered resistant strains
• 60 day course of antibiotics
• Ciprofloxacin
– fluoroquinolone
– 500 mg tablet every 12h or 400 mg IV
every 12h
– Inhibits DNA synthesis
• Doxycycline
– 6-deoxy-tetracycline
– 100 mg tablet every 12h or 100 mg IV
every 12h
– Inhibits protein synthesis
• For inhalational, need another
antimicrobial agent
– clindamycin
– rifampin hrax.html
– chloramphenico
Dr.T.V.Rao MD 66
Trends on Vaccine
• BioThrax/Anthrax vaccine absorbed
– Made by Bioport
– Route of exposure not important
• Administered subcutaneously
– .5mL at 0, 2, and 4 weeks, and at 6, 12, & 18 months, & booster doses at 1 yr
intervals
• A December 22, 2003 ruling temporarily halted the Department of Defense’s anthrax
vaccination program
– Lifting of that injunction on January 7, 2004
Dr.T.V.Rao MD 67
Immune Protection Against Anthrax
• Live cellular vaccines
– "Sterne" type live spore (toxigenic, noncapsulating)
– Former USSR STI live spore (toxigenic, non-
capsulating)
– "Pasteur" type (mixed culture, reduced virulence)
• Sterile, acellular vaccines
– US "anthrax vaccine adsorbed" (AVA)—not licensed
for use in civilian populations
– UK "anthrax vaccine precipitated" (AVP)
• Recombinant PA research vaccines
– AI3+; Freund’s; Saponin, Monophosphoryl lipid A; Ribi
Dr.T.V.Rao MD 68
Vaccination
• Cell-free filtrate
• Licensed in 1970
• At risk
– Wool mill workers
– Veterinarians
– Lab workers
– Livestock handlers
– Military personnel
Dr.T.V.Rao MD 69
Vaccine Schedule
• 3 injections at two-week intervals
• 3 injections 6 months apart
• Annual booster
Dr.T.V.Rao MD 70
Recommended Post exposure Prophylaxis to
Prevent Inhalational Anthrax
Initial Therapy Duration
Adults Ciprofloxacin 60 days
(including pregnant 500 mg PO BID
women and OR
immunocompromised) Doxycycline
100 mg PO BID
Children Ciprofloxacin* 60 days
10–15 mg/kg PO Q 12 hrs. Change to
OR amoxicillin
Doxycycline: if susceptible
>8 yrs. and >45 kg: 100 mg PO BID
>8 yrs. and <45 kg: 2.2 mg/kg PO BID
<8 yrs.: 2.2 mg/kg PO BID
*Ciprofloxacin not to exceed 1 gram daily in children
Patient information sheets at www.bt.cdc.gov
Dr.T.V.Rao MD 71
Precautions to Health care Workers
• Standard contact
precautions. Avoid
direct contact
with wound or
wound drainage.
Dr.T.V.Rao MD 72
Anthrax Has Been Used As a
Bioweapon
• Because it is deadly, noncontagious, and dispersed
by spores, anthrax has always been considered a
good candidate for a bioweapon (table 3). Late in
2001, this possibility became a reality. Letters
containing anthrax spores were sent to several
news reporters and two United States Senators.
Five people died of inhalational anthrax as a result
of exposure to these spores.
Dr.T.V.Rao MD 73
Weaponization & Bacillus Anthracis:
Why is this Agent Considered to be the Department of Defense’s
Number-One/Two Biological Threat?
Dr.T.V.Rao MD 74
Analysis of the 2001 US Anthrax
Attacks
*Also believed to be three or more other envelopes that were never found
Dr.T.V.Rao MD 75
Anthrax Cases, 2001
• 22 cases
– 11 cutaneous
– 11 inhalational
• 5 deaths (all inhalational)
– Index case in Florida
– 2 postal workers in Maryland
– Hospital supply worker in NYC
– Elderly farm woman in Connecticut
Dr.T.V.Rao MD 76
Analysis of the 2001 US Anthrax Attacks
• Anthrax in Envelopes
– Concentration of about 1 trillion spores per gram
– 2 grams anthrax per envelope
– Each letter contained ~200 million times average LD50
– All anthrax was unmilled, contained a certain type of
silica to reduce electrostatic charges and was of the
Ames strain
– all characteristic of US weapons-grade anthrax
Dr.T.V.Rao MD 77
Created by Dr.T.V.Rao MD for “ e
“ learning resources in Developing
World
• Email
doctortvrao@gmail.com
Dr.T.V.Rao MD 78